Sibylle Mueller

Title: Sibylle Mueller: Innovator in Pharmaceutical Chemistry

Introduction

Sibylle Mueller is a prominent inventor based in Frenkendorf, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. Her work has led to the granting of a patent that showcases her expertise and dedication to advancing healthcare solutions.

Latest Patents

Sibylle Mueller holds a patent for her invention related to Sacubitril calcium salts. The patent describes polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. This calcium salt is particularly useful in treating various conditions and disorders that respond to the inhibition of neutral endopeptidases. Her innovative approach has the potential to improve therapeutic outcomes for patients.

Career Highlights

Sibylle Mueller is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in pharmaceuticals. Her dedication to her work is evident in her successful patent application and the impact it may have on future treatments.

Collaborations

Sibylle has worked alongside esteemed colleagues such as David Hook and Bin Hu. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical research.

Conclusion

Sibylle Mueller's contributions to pharmaceutical chemistry exemplify the importance of innovation in healthcare. Her patent for Sacubitril calcium salts highlights her commitment to improving patient care through scientific advancements. Her work continues to inspire future generations of inventors in the field.